Works matching IS 1021335X AND DT 2018 AND VI 39 AND IP 2


Results: 49
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.

    Published in:
    Oncology Reports, 2018, v. 39, n. 2, p. 537, doi. 10.3892/or.2017.6149
    By:
    • Ochiai, Yushi;
    • Sano, Emiko;
    • Okamoto, Yutaka;
    • Yoshimura, Sodai;
    • Makita, Kotaro;
    • Yamamuro, Shun;
    • Ohta, Takashi;
    • Ogino, Akiyoshi;
    • Tadakuma, Hisashi;
    • Ueda, Takuya;
    • Nakayama, Tomohiro;
    • Hara, Hiroyuki;
    • Yoshino, Atsuo;
    • Katayama, Yoichi
    Publication type:
    Article
    41
    42
    43

    Screening and antitumor effect of an anti-CTLA-4 nanobody.

    Published in:
    Oncology Reports, 2018, v. 39, n. 2, p. 511, doi. 10.3892/or.2017.6131
    By:
    • Wan, Ruirong;
    • Liu, Aiqun;
    • Hou, Xiaoqiong;
    • Lai, Zongqiang;
    • Li, Jieping;
    • Yang, Nuo;
    • Tan, Juntao;
    • Mo, Fengzhen;
    • Hu, Zixi;
    • Yang, Xiaomei;
    • Zhao, Yongxiang;
    • Lu, Xiaoling
    Publication type:
    Article
    44
    45
    46
    47
    48
    49